Philosophical issues in the prodromal phase of psychosis

Current Pharmaceutical Design

Volumn 18, Issue 4, 2012, Pages 596-605

  Broome, Matthew ^a,b,c   Fusar Poli, Paolo ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c University of Warwick and Coventry and Warwickshire Partnership NHS Trust   (United Kingdom)

Author keywords

Delusions; Neuroimaging; Neuroscience; Philosophy; Prodrome; Psychiatry; Psychosis; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT;

ANXIETY; ARTICLE; BRAIN; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; HUMAN; MEDICAL ETHICS; NEUROSCIENCE; PHILOSOPHY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL PSYCHIATRY;

EARLY DIAGNOSIS; HUMANS; PHILOSOPHY, MEDICAL; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84856520324     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316190     Document Type: Article

References (115)

1. Broome M, Bortolotti L, editors. Psychiatry as Cognitive Neuroscience: Philosophical Perspectives. Oxford: Oxford University Press; 2009.
2. Bullmore ET, Woodruff PW, Wright IC, Rabe-Hesketh S, Howard RJ, Shuriquie N, et al. Does dysplasia cause anatomical dysconnectivity in schizophrenia? Schizophr Res. 1998 Mar 10;30(2):127-35.
3. McDonald C, Fearon P, Murray R. Neurodevelopmental hypothesis of schizophrenia 12 years on: data and doubts. In: Rapoport J, editor. Childhood Onset of Adult Psychopathology. Washington: American Psychiatric Press; 1999. p. 193-220.
4. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed). 1987 Sep 19;295(6600):681-2.
5. Boydell J, van Os J, McKenzie K, Murray RM. The association of inequality with the incidence of schizophrenia--an ecological study. Soc Psychiatry Psychiatr Epidemiol. 2004 Aug;39(8):597-9.
6. Morgan C, Kirkbride J, Leff J, Craig T, Hutchinson G, McKenzie K, et al. Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychol Med. [Research Support, Non-U.S. Gov't]. 2007 Apr;37(4):495-503.
7. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol. 2004 Mar;7 Suppl 1:S7-S13.
8. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature. 2010 Nov 11;468(7321):203-12.
9. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002 May;59(5):449-56.
10. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994 Nov 19;344(8934):1398-402.
11. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho B-C, Andreasen NC. Longitudinal Assessment of Premorbid Cognitive Functioning in Patients With Schizophrenia Through Examination of Standardized Scholastic Test Performance. Am J Psychiatry. 2002 July 1, 2002;159(7):1183-9.
12. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a metaanalysis. Neurosci Biobehav Rev. 2011 Jan;35(3):573-88.
13. Thompson A, Bartholomeusz C, Yung A. Social cognition deficits and the "Ultra High Risk" for psychosis population: a review of the literature. Early Intervention in Psychiatry. Early Intervention in Psychiatry. 2011:in press.
14. Bora E, Yucel M, Pantelis C. Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res. 2009 Apr;109(1-3):1-9.
15. Sergi MJ, Fiske AP, Horan WP, Kern RS, Kee KS, Subotnik KL, et al. Development of a measure of relationship perception in schizophrenia. Psychiatry Res. 2009 Mar 31;166(1):54-62.
16. Marwick K, Hall J. Social cognition in schizophrenia: a review of face processing. Br Med Bull. 2008;88(1):43-58.
17. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry. 2000 Nov;57(11):1053-8.
18. Broome MR, Woolley JB, Tabraham P, Johns LC, Bramon E, Murray GK, et al. What causes the onset of psychosis? Schizophr Res. [Review]. 2005 Nov 1;79(1):23-34.
19. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev. 2001 Nov;21(8):1125-41.
20. Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry. 2004 Oct;185:298-305.
21. Verdoux H, van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res. 2002 Mar 1;54(1-2):59-65.
22. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistenceimpairment model of psychotic disorder. [Review] [136 refs]. 2009.
23. Broome MR, Woolley JB, Johns LC, Valmaggia LR, Tabraham P, Gafoor R, et al. Outreach and support in South London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. European Psychiatry. 2005;20:372-8.
24. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58(2):158-64.
25. McGlashan TH, Miller TJ, Woods SW. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull. 2001;27(4):563-70.
26. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry. 2004 Oct;185:291-7.
27. Riecher-Rossler A, Gschwandtner U, Borgwardt S, Aston J, Pfluger M, Rossler W. Early detection and treatment of schizophrenia: how early? Acta Psychiatr Scand Suppl. 2006(429):73-80.
28. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22(2):353-70.
29. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis - A step towards indicated prevention of schizophrenia. Br J Psychiatry. 1998;172:14-20.
30. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk (prodromal) group. Schizophr Res. 2003 Mar 1;60(1):21-32.
31. Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Res. 2002;54(1-2):177-86.
32. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton M, Barale F, et al. Predicting psychosis: a meta-analysis of evidence. Arch Gen Psychiatry. 2011:submitted.
33. van Os J. A salience dysregulation syndrome. The British Journal of Psychiatry. 2009 February 1, 2009;194(2):101-3.
34. Van Os J, Delespaul P. Toward a world consensus on prevention of schizophrenia. Dialogues Clin Neurosci. 2005;7(1):53-67.
35. Thompson A, Nelson B, Yung AR. Predictive validity of clinical variables in the at risk for psychosis population: international comparisons with results from the North American Prodrome Longitudinal Study. Schizophr Res. 2010:Oct 28 Epub.
36. Schimmelmann BG, Michel C, Schaffner N, Schultze-Lutter F. What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis? Schizophr Res. 2011 Jan;125(1):99-100.
37. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al. Validation of prodromal criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res. 2008 Oct;105(1-3):10-7.
38. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007 May;33(3):673-81.
39. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007 May;33(3):673-81.
40. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology. 2005 Jun;44(Pt 2):181-91.
41. Escher S, Romme M, Buiks A, Delespaul P, Van Os J. Independent course of childhood auditory hallucinations: a sequential 3-year follow-up study. Br J Psychiatry Suppl. 2002 Sep;43:s10-8.
42. Yung AR, Nelson B, Thompson A, Wood SJ. The psychosis threshold in ultra high risk (prodromal) research: is it valid? Schizophr Res. 2010(120):1-6.
43. Winton-Brown TT, Harvey SB, McGuire PK. The diagnostic significance of BLIPS (Brief Limited Intermittent Psychotic Symptoms) in Psychosis. Schizophr Res. 2011 Mar 23.
44. Nelson B, Yuen K, Yung AR. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Schizophr Res. 2011 Jan;125(1):62-8.
45. Fusar-Poli P, Borgwardt S. Integrating the negative psychotic symptoms in the high risk criteria for the prediction of psychosis. Med Hypotheses. 2007;69(4):959-60.
46. Raballo A, Nelson B, Thompson A, A.Y. The comprehensive assessment of at-risk mental states: from mapping the onset to mapping the structure. Schizophr Res. 2011;127(1-3):107-14.
47. Broome MR, McGuire PK. Imaging and delusions. In: Freeman D, Bentall R, Garety PA, editors. Persecutory delusions: assessment, theory and treatment. Oxford: Oxford University Press; 2008. p. 281-301.
48. Freeman D. Suspicious minds: the psychology of persecutory delusions. Clinical Psychology Review. 2007 May;27(4):425-57.
49. Bortolotti L, Broome M. Delusional beliefs and reasoning giving. Philosophical Psychology. 2008;21(6):821-41.
50. Bortolotti L, Broome M. The future of scientific psychiatry. In: Broome M, Bortolotti L, editors. Psychiatry as cognitive neuroscience: philosophical perpsctives. Oxford: Oxford University Press; 2009. p. 365-75.
51. Bortolotti L, Broome MR. A role for ownership and authorship in the analysis of thought insertion. Phenomenology and Cognitive Sciences. 2009;8:205-24.
52. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003 Jan;160(1):13-23.
53. Jaspers K. General Psychopathology. Baltimore: Johns Hopkins University Press; 1959/1997.
54. Freeman D, Garety PA. Comments on the content of persecutory delusions: Does the definition need clarifying? British Journal of Clinical Psychology. 2000;39:407-14.
55. Fusar-Poli P, Broome MR. Conceptual issues in psychiatric neuroimaging. Curr Opin Psychiatry. 2006 Nov;19(6):608-12.
56. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis. Schizophr Res. 2005 Nov 1;79(1):59-68.
57. Broome MR, Johns LC, Valli I, Woolley JB, Tabraham P, Brett C, et al. Delusion formation and reasoning biases in those at clinical high risk for psychosis. 2007 December 1, 2007;191(51):s38-42.
58. Howes O, Montgomery A, Asselin M, Valli I, Tabraham P, Johns L, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry. 2009;66(1):13-20.
59. Howes O, Bose S, Turkheimer F, Valli I, Egerton A, Stahl D, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry. 2011 Mar 1.
60. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz R, Drewe J, et al. Neuroimaging predictors of transition to psychosis - A systematic review and meta-analysis. Neuroscience and Biobehavioural Reviews. 2010;34(8):1207-22.
61. Morgan C, McKenzie K, Fearon P. Introduction. In: Morgan C, McKenzie K, Fearon P, editors. Society and Psychosis. Cambridge: Cambridge Univeristy Press; 2008. p. 1-10.
62. Cantor-Graae E, Selten J. Schizophrenia and migration: A metaanalysis. Schizophr Res. 2004 15 February 2004;67(1, Suppl 1):63.
63. Selten J-P, Cantor-Graae E. Social defeat: risk factor for schizophrenia?[see comment]. Br J Psychiatry. 2005 Aug;187:101-2.
64. Selten J-P, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Current Opinion in Psychiatry. 2007 Mar;20(2):111-5.
65. Fearon P, Kirkbride JB, Morgan C, Dazzan P, Morgan K, Lloyd T, et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study.[see comment]. Psychol Med. [Multicenter Study Research Support, Non-U.S. Gov't]. 2006 Nov;36(11):1541-50.
66. Fearon P, Morgan C. Environmental factors in schizophrenia: the role of migrant studies. Schizophr Bull. 2006 Jul;32(3):405-8.
67. Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study.[see comment]. Archives of General Psychiatry. [Comparative Study Multicenter Study Research Support, Non-U.S. Gov't]. 2006 Mar;63(3):250-8.
68. Kirkbride JB, Morgan C, Fearon P, Dazzan P, Murray RM, Jones PB, et al. Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med. [Research Support, Non-U.S. Gov't]. 2007 Oct;37(10):1413-25.
69. Morgan C, Abdul-Al R, Lappin JM, Jones P, Fearon P, Leese M, et al. Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. Br J Psychiatry. [Multicenter Study Research Support, Non-U.S. Gov't]. 2006 Nov;189:446-52.
70. Morgan C, Fearon P, Hutchinson G, McKenzie K, Lappin JM, Abdul-Al R, et al. Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychol Med. [Comparative Study Research Support, Non-U.S. Gov't]. 2006 Feb;36(2):239-47.
71. Morgan C, Mallett R, Hutchinson G, Bagalkote H, Morgan K, Fearon P, et al. Pathways to care and ethnicity. 2: Source of referral and help-seeking. Report from the AESOP study. Br J Psychiatry. [Research Support, Non-U.S. Gov't]. 2005 Apr;186:290-6.
72. Morgan C, Mallett R, Hutchinson G, Bagalkote H, Morgan K, Fearon P, et al. Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. Br J Psychiatry. [Research Support, Non-U.S. Gov't]. 2005 Apr;186:281-9.
73. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis. Schizophr Res. 2005 Nov 1;79(1):59-68.
74. Howes OD, Kapur S. The Dopamine Hypothesis of Scizophrenia: Version III - The Final Common Pathway. Schzophrenia Bulletin. 2009.
75. van Os J. A salience dysregulation syndrome. British Journal of Psychiatry. 2009;194:101-3.
76. Myin-Germeys I, Delespaul P, van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med. 2005 May;35(5):733-41.
77. Myin-Germeys I, Krabbendam L, Delespaul P, van Os J. Can cognitive deficits explain differential sensitivity to life events in psychosis? Social Psychiatry & Psychiatric Epidemiology. 2003 May;38(5):262-8.
78. Myin-Germeys I, Krabbendam L, Delespaul PAEG, Van Os J. Do life events have their effect on psychosis by influencing the emotional reactivity to daily life stress? Psychol Med. 2003 Feb;33(2):327-33.
79. Myin-Germeys I, Peeters F, Havermans R, Nicolson NA, DeVries MW, Delespaul P, et al. Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study. Acta Psychiatrica Scandinavica. 2003 Feb;107(2):124-31.
80. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry. 2001 Dec;58(12):1137-44.
81. Ellett L, Freeman D, P G. The psychological effect of an urban environment on inidviduals with persecutory delusions: The Camberwell walk study. Psychol Med. in press.
82. Rowlands M. Externalism: Putting mind and world back together again. Chesham, Bucks: Acumen; 2003.
83. McGorry PD, Yung A, Phillips L. Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res. 2001 Aug 1;51(1):17-29.
84. McGuire P. Prodromal intervention: the need for evaluation. The Journal of Mental Health. 2002;11:469-70.
85. Warner R. Problems with early and very early intervention in psychosis. British Journal of Psychiatry, 187 British Journal of Psychiatry. 2005;Suppl 48:s104-s7.
86. Miller TJ, McGlashan TH. Early identification and intervention in psychotic illness. Conn Med. 2000 Jun;64(6):339-41.
87. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002 May;159(5):863-5.
88. Yung AR, Yuen HP, Berger GE, Francey S, Hung T-C, McGorry P. Declining transition rate in Ultra High Risk (prodromal) services: dilution or reduction of risk? Schizophenia Bulletin. 2007;33:673-81.
89. Haroun N, Dunn L, Haroun A, Cadenhead K. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin. 2006;32:166-78.
90. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebocontrolled trial. Archives of General Psychiatry. 2010 Feb;67(2):146-54.
91. Campbell J. What Does Rationality Have To Do With Psychological Causation? Propositional Attitudes as Control Variables and as Mechanisms. In: Broome M, Bortolotti L, editors. Psychiatry as Cognitive Neuroscience: Philosophical Perspectives Oxford: Oxford University Press; 2009. p. 137-49.
92. Heckers S. Who Is at Risk for a Psychotic Disorder? Schizophr Bull (2009) 35(5): 847-850 first published online July 24, 2009 doi:10.1093/schbul/sbp078.
93. Carpenter W.T. Anticipating DSM-V: Should Psychosis Risk Become a Diagnostic Class? Schizophr Bull (2009) 35(5): 841-843 first published online July 24, 2009 doi:10.1093/schbul/sbp071.
94. Yung AR, Nelson B, Thompson A, Wood SJ. Should a risk syndrome for psychosis be included in the DSM-V? Schizophr Res. 2010;120:7-15.
95. Drake RJ, Lewis SW. Valuing prodromal psychosis: what do we get and what is the price? Schizophr Res. 2010 Jul;120(1-3):38-41.
96. Bortolotti L, Widdows H. The right not to know: the case of psychiatric disorders. Journal of Medical Ethics. 2011 June 9, 2011.
97. McGorry P. Head to head. Is early intervention in the major psychiatric disorders justified? Yes.British Medical Journal. 2008;337:a695.
98. Valmaggia LR, McCrone P, Knapp M, Woolley JB, Broome MR, Tabraham P, et al. Economic impact of early intervention in people at high risk of psychosis. Psychological Medicine. 2009;39(10):1617-26.
99. McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, et al. Intervention in individuals at ultra high risk for psychosis: a review and future directions. Journal of Clinical Psychiatry. 2009;70(9):1206-12.
100. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez- Toledo JP, Zarate CA, Jr., et al. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. Journal of Clinical Psychiatry. 2009;70(4):458-66.
101. Whitty P, Clarke M, McTigue O, Browne S, Kamali M, Larkin C, et al. Diagnostic stability four years after a first episode of psychosis. Psychiatric Services. 2005;56(9):1084-8.
102. Raballo A, Laroi F. Clinical staging: a new scenario for the treatment of psychosis. Lancet. 2009;374(9687):365-7.
103. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australian & New Zealand Journal of Psychiatry. 2006;40(8):616-22.
104. Fusar-Poli P, Borgwardt S, Crescini A, D'Este G, Kempton M, Lawrie S, et al. Neuroanatomy of Vulnerability to Psychosis: A Voxel-Based Meta-Analysis. Neurosci Biobehav Rev. 2010 Dec 16.
105. Broome MR, Fusar-Poli P, Matthiasson P, Woolley JB, Valmaggia L, Johns LC, et al. Neural correlates of visuospatial working memory in the?'at-risk mental state? Psychological Medicine. 2010;40(12):1987-99.
106. Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, et al. Neural correlates of executive function and working memory in the 'at-risk mental state'. The British Journal of Psychiatry. 2009 January 1, 2009;194(1):25-33.
107. Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, et al. Neural correlates of movement generation in the 'at-risk mental state'. Acta Psychiatrica Scandinavica. [Research Support, Non-U.S. Gov't]. 2010 Oct;122(4):295-301.
108. Broome M, Bortolotti L. Mental illness as mental: in defence of psychological realism. Humana Mente. 2009(11):25-43.
109. Broome M, Bortolotti L. What's wrong with 'mental' disorders? Psychological Medicine. 2010;40(11):1783-5.
110. Fusar-Poli P, Broome M, Barale F, Stanghellini G. Why is psychiatric imaging clinically unreliable? Epistemological perspectives in clinical neuroscience. Psychother Psychosom. 2009;78(5):320-1.
111. Broome MR. Taxonomy and Ontology in Psychiatry: A Survey of Recent Literature Philosophy, Psychiatry, and Psychology. 2006;13(4):303-19.
112. McDowell J. Mind and World. Cambridge, Massachusetts: Harvard University Press; 1996.
113. McDowell J. Precis of Mind and World. Philosophy and Phenomenological Research 1998;58(2):365-8.
114. Broome MR. Taxonomy and Ontology in Psychiatry: A Survey of Recent Literature. Philosophy, Psychiatry, and Psychology. 2006;13(4): 303-19.
115. an der Heiden W, Hafner H. The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2000;250(6):292-303.